Expanding Access to GLP-1 Medications
Linda Yaccarino, CEO of eMed, and Tom Brady, Chief Wellness Officer, are leading a charge to transform healthcare. Their focus is on increasing accessibility to GLP-1 medications. These treatments have shown significant promise in supporting long-term health improvements, particularly for conditions like heart and liver disease.
Yaccarino highlights the success of eMed’s approach, citing a 90% adherence rate. This has been achieved through the use of artificial intelligence and clinical support. Such tools have been instrumental in ensuring patients stick to their treatment plans.
Democratizing Health and Wellness
Brady underscores the necessity of democratizing health access. For him, the goal is to provide essential treatments to everyone, not just professional athletes. Brady stresses the importance of instilling long-term behavioral changes that improve wellbeing for employees.
He draws parallels between his football career and this healthcare venture. As he learned to maintain his physical health, he wants everyday Americans to have similar guidance.
The NFL Mindset in Healthcare
While speaking on FOX Business’ “The Claman Countdown,” Brady keeps focused on the fundamentals. This mirrors his approach on the football field, where hard work, overcoming challenges, and being a supportive team player have always been central to his success.
Brady believes these same principles can enhance healthcare outcomes for everyone. Accountability, discipline, and service to others are critical values that drive success, whether in sports or health.
Impact of GLP-1 Medications
Brady praises the effectiveness of GLP-1 medications in initiating a wellness journey for many. He notes there is no contest in their current success, helping individuals kickstart and maintain their path to health improvement.
The integration of these medicines with eMed’s support system aims to sustain this journey, ensuring individuals achieve their health goals.

Understanding Medicare Extra Help and Its Benefits
New Restrictions on U.S.-China Science Collaboration
Trump’s Remarks on Childhood Vaccines Spark Debate
CDC Reports Drug-Resistant Fungus Candida Auris Cases Across 27 States
Apple Watch Series 11 Discounted to Lowest Price
Medicaid Coverage and Its Impact on Pediatric Care